Fisher BJ, Pugh SL, Macdonald DR, Chakravatri A, et al. Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424. Int J Radiat Oncol Biol Phys 2020 Apr 3. pii: S0360-3016(20)30957.
PMID: 32251755